Authors |
Patients (n) |
Surgery |
pTNM stage |
Adjuvant treatment |
DFS |
Bouassida et al. [1] |
1 |
Cholecystectomy |
pT4N0M0 |
Radiotherapy |
12 months |
Kurniali et al. [14] |
1 |
Right trisectionectomy and bile duct resection |
ND |
Gemzar |
12 months |
Soufi et al. [15] |
4 |
Cholecystectomy |
ND |
Radiotherapy |
34 months |
Gold et al. [11] |
3 |
Tumor resection |
ND |
Chemoradiotherapy(5FU) |
44.9% at 5 years |
Mingoli et al. [16] |
2 |
Tumor resection |
ND |
Chemoradiotherapy (5FU) |
3 months |
Rekik et al. [7] |
1 |
Cholecystectomy |
pT3N0M0 |
Chemoradiotherapy(5FU) |
12 months |
Waisberg et al. [2] |
1 |
Cholecystectomy |
ND |
Chemoradiotherapy(5FU) |
6 months |
Bourmèche et al. [9] |
1 |
Cholecystectomy |
pT2N1M0 |
Chemoradiotherapy (5FU) |
216 months |
Our case |
1 |
Cholecystectomy + segmentectomy |
pT3N0M0 |
Folfox |
4 months |
|
Note: ND: Not Described; DFS: Disease Free Survival |
Table 2: Adjuvant treatment after curative resection for gallbladder squamous-cell carcinoma. |